早期复苏方案对脓毒症及低血压成人住院死亡率的影响:一项随机临床试验
在赞比亚一家1500张床位的转诊医院急诊科开展的随机临床试验,纳入212例脓毒症合并低血压成人,其中89.5%为HIV阳性。早期复苏方案组住院死亡率为48.1%,常规治疗组为33.0%,组间差异为15.1%(95%CI 2.0%-28.3%),相对危险度为1.46(95%CI 1.04-2.05;P=0.03)。在资源有限环境中,早期复苏方案相比常规治疗增加了住院死亡率。
要点
- 脓毒症合并低血压成人中,早期复苏方案组住院死亡率为48.1%,常规治疗组为33.0%。
- 早期复苏方案组6小时内静脉输液量中位数为3.5L,常规治疗组为2.0L(平均差1.2L,95%CI 1.0-1.5L;P<0.001)。
- 早期复苏方案组14.2%接受血管加压药,常规治疗组为1.9%(组间差异12.3%,95%CI 5.1%-19.4%;P<0.001)。
核心结论
- 在资源有限环境中,对脓毒症合并低血压成人(多数HIV阳性)采用早期复苏方案(静脉输液和血管加压药)相比常规治疗增加了住院死亡率。
- 需要进一步研究以了解静脉液体推注和血管加压药在不同中低收入临床环境和患者人群中对脓毒症患者的影响。
研究设计与样本
- 随机临床试验,在赞比亚一家1500张床位的转诊医院急诊科开展,纳入212例脓毒症(疑似感染加≥2项全身炎症反应综合征标准)合并低血压(收缩压≤90 mm Hg或平均动脉压≤65 mm Hg)成人,2012年10月22日至2013年11月11日入组,数据收集于2013年12月9日结束。
- 患者按1:1随机分为早期复苏方案组(n=107)和常规治疗组(n=105),最终209例完成研究并纳入分析(平均[SD]年龄36.7[12.4]岁;117例男性[56.0%];187例[89.5%]HIV阳性)。
主要发现
- 主要结局住院死亡率在早期复苏方案组为51/106例(48.1%),常规治疗组为34/103例(33.0%),组间差异15.1%(95%CI 2.0%-28.3%),相对危险度1.46(95%CI 1.04-2.05;P=0.03)。
- 急诊就诊后6小时内,早期复苏方案组静脉输液量中位数为3.5 L(四分位距2.7-4.0 L),常规治疗组为2.0 L(四分位距1.0-2.5 L),平均差1.2 L(95%CI 1.0-1.5 L;P<0.001)。
- 早期复苏方案组15例(14.2%)接受血管加压药,常规治疗组2例(1.9%)接受血管加压药,组间差异12.3%(95%CI 5.1%-19.4%;P<0.001)。
关键数值与推荐
- 早期复苏方案包括:静脉液体推注并监测颈静脉压、呼吸频率和动脉血氧饱和度;使用血管加压药以平均动脉压≥65 mm Hg为目标;血红蛋白水平<7 g/dL的患者接受输血。
- 常规治疗由治疗临床医生决定血流动力学管理。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以了解静脉液体推注和血管加压药在不同中低收入临床环境和患者人群中对脓毒症患者的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The effect of an early resuscitation protocol on sepsis outcomes in developing countries remains unknown. OBJECTIVE: To determine whether an early resuscitation protocol with administration of intravenous fluids, vasopressors, and blood transfusion decreases mortality among Zambian adults with sepsis and hypotension compared with usual care. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 212 adults with sepsis (suspected infection plus ≥2 systemic inflammatory response syndrome criteria) and hypotension (systolic blood pressure ≤90 mm Hg or mean arterial pressure ≤65 mm Hg) presenting to the emergency department at a 1500-bed referral hospital in Zambia between October 22, 2012, and November 11, 2013. Data collection concluded December 9, 2013. INTERVENTIONS: Patients were randomized 1:1 to either (1) an early resuscitation protocol for sepsis (n = 107) that included intravenous fluid bolus administration with monitoring of jugular venous pressure, respiratory rate, and arterial oxygen saturation and treatment with vasopressors targeting mean arterial pressure (≥65 mm Hg) and blood transfusion (for patients with a hemoglobin level <7 g/dL) or (2) usual care (n = 105) in which treating clinicians determined hemodynamic management. MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality and the secondary outcomes included the volume of intravenous fluid received and receipt of vasopressors. RESULTS: Among 212 patients randomized to receive either the sepsis protocol or usual care, 3 were ineligible and the remaining 209 completed the study and were included in the analysis (mean [SD] age, 36.7 [12.4] years; 117 men [56.0%]; 187 [89.5%] positive for the human immunodeficiency virus). The primary outcome of in-hospital mortality occurred in 51 of 106 patients (48.1%) in the sepsis protocol group compared with 34 of 103 patients (33.0%) in the usual care group (between-group difference, 15.1% [95% CI, 2.0%-28.3%]; relative risk, 1.46 [95% CI, 1.04-2.05]; P = .03). In the 6 hours after presentation to the emergency department, patients in the sepsis protocol group received a median of 3.5 L (interquartile range, 2.7-4.0 L) of intravenous fluid compared with 2.0 L (interquartile range, 1.0-2.5 L) in the usual care group (mean difference, 1.2 L [95% CI, 1.0-1.5 L]; P < .001). Fifteen patients (14.2%) in the sepsis protocol group and 2 patients (1.9%) in the usual care group received vasopressors (between-group difference, 12.3% [95% CI, 5.1%-19.4%]; P < .001). CONCLUSIONS AND RELEVANCE: Among adults with sepsis and hypotension, most of whom were positive for HIV, in a resource-limited setting, a protocol for early resuscitation with administration of intravenous fluids and vasopressors increased in-hospital mortality compared with usual care. Further studies are needed to understand the effects of administration of intravenous fluid boluses and vasopressors in patients with sepsis across different low- and middle-income clinical settings and patient populations. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01663701.
引用
- Andrews B, Semler MW, Muchemwa L, et al. Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial. JAMA. 2017. PMID: 28973227. doi:10.1001/jama.2017.10913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。